Christa Nagel

Christa Nagel's research focuses on gynecologic cancers, especially ovarian, endometrial, cervical, and vulvar cancers, with an emphasis on clinical trials testing new drug combinations and treatment approaches. Work includes large multi-institutional trials evaluating chemotherapy, targeted therapies (like PARP inhibitors and immunotherapy agents), radiation and brachytherapy techniques, and studies on quality of life and surgical outcomes for cancer patients. The publication record reflects participation in cooperative group clinical trials (such as NRG Oncology studies) alongside case reports and outcomes research.

Publication output has grown substantially over the last decade, rising sharply from a handful of papers per year before 2022 to over 40-75 publications annually in 2023-2025, likely reflecting increased involvement in large collaborative clinical trial reporting.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026